首页|A natural nano-platform:Advances in drug delivery system with recombinant high-density lipoprotein

A natural nano-platform:Advances in drug delivery system with recombinant high-density lipoprotein

扫码查看
Developing natural nano-platforms with high biocompatibility and natural targeting ability represents great significance for drug delivery.High-density lipoprotein(HDL),a natural lipid-protein complex,plays important roles in physiological activities,particularly in reverse cholesterol transport(RCT)and be closely associated with atherosclerotic cardiovascular diseases.Recent studies have demonstrated that HDLs have the potential to serve as ideal drug carriers.Recombinant HDLs(rHDLs)have been used to en-capsulate substances such as small interfering RNA(siRNA),drugs,and contrast agents,fully utilizing the biocompatibility and targeting ability of rHDL in the body and providing new strategies for drug delivery and disease treatment.In this review,we discussed in detail the basic principles of HDL as a drug delivery system,the mechanisms of targeted drug delivery,and several methods for preparing HDL nanoparticles.Afterward,we comprehensively reviewed the applications of HDL as a drug carrier in cardiovascular dis-eases,cancer treatment(such as glioblastoma,breast cancer,hepatocellular carcinoma and urologic can-cers)and some other fields.Finally,we reviewed the therapeutic effects and safety of HDL nanoparticles in clinical studies.Through a review and summary of these research advances,we aim to fully understand the potential of HDL as a drug carrier in clinical applications,providing valuable references and guidance for future research and expedites the translational application of HDL as drug carriers.

High-density lipoproteinsDrug deliveryApolipoproteinTargeting mechanismsHDL nanoparticle preparationCardiovascular diseaseCancer treatment

Zhilong Xie、Guohui Zhang、Ya Meng、Yefei Tong、Jian Deng、Honghui Li、Qingqing Ma、Shisong Han、Wenjun Ni

展开 >

Zhuhai Clinical Medical College of Jinan University(The Department of Urology,Zhuhai People's Hospital),Zhuhai 519050,China

Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Institute of Translational Medicine,Zhuhai People's Hospital(Zhuhai Clinical Medical College of Jinan University),Zhuhai 519050,China

The Second Clinical Medical College,Guangdong Medical University,Dongguan 523808,China

Guizhou Aerospace Hospital,Guizhou 563099,China

展开 >

2024

中国化学快报(英文版)
中国化学会

中国化学快报(英文版)

CSTPCD
影响因子:0.771
ISSN:1001-8417
年,卷(期):2024.35(11)